Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
Nicole KnapeJi-Hye ParkChris B AgalaPhilip SpanheimerMonica MorrowStephanie M Downs-CannerXavier L BaldwinPublished in: Annals of surgical oncology (2022)
Our study suggests that SLNB could potentially be omitted in select postmenopausal women with cT1-2 N0 HR+/HER2- special histologic subtype breast cancer when ODX RS is available.
Keyphrases